Eradication of HCV induced by direct-acting antivirals is associated with a 79% reduction in HCC risk.

被引：0
|
作者：
Ioannou, George N. [1 ,2 ]
Green, Pamela [2 ]
Berry, Kristin [2 ]
机构：
[1] Univ Washington, Seattle, WA 98195 USA
[2] Vet Affairs Puget Sound Healthcare Syst, Seattle, WA USA
来源：
HEPATOLOGY | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
142
引用
收藏
页码：82A / 83A
页数：2
相关论文
共 50 条
  • [1] Mortality associated with the treatment of HCV with direct-acting antivirals
    Laurain, Anne
    Kramer, Laura
    Sultanik, Philippe
    Vallet-Pichard, Anais
    Sogni, Philippe
    Pol, Stanislas
    [J]. GUT, 2018, 67 (01) : 197 - +
  • [2] HCV Eradication with Direct-Acting Antivirals Does Not Impact HCC Progression on the Waiting List or HCC Recurrence after Liver Transplantation
    Emamaullee, Juliet A.
    Bral, Mariusz
    Meeberg, Glenda
    Montano-Loza, Aldo J.
    Bain, Vincent G.
    Burak, Kelly Warren
    Bigam, David
    Shapiro, A. M. James
    Kneteman, Norman
    [J]. CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 2019
  • [3] The impact of HCV eradication by direct-acting antivirals on the transition of precancerous hepatic nodules to HCC: A prospective observational study
    Toyoda, Hidenori
    Kumada, Takashi
    Tada, Toshifumi
    Mizuno, Kazuyuki
    Sone, Yasuhiro
    Akita, Tomoyuki
    Tanaka, Junko
    Johnson, Philip J.
    [J]. LIVER INTERNATIONAL, 2019, 39 (03) : 448 - 454
  • [4] Editorial - Direct-acting antivirals therapy in HCV patients with HCC: lights and shadow
    Rinaldi, B.
    Rosato, V.
    Galiero, R.
    Vetrano, E.
    Fasano, M.
    Rinaldi, L.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (24) : 7622 - 7625
  • [5] Exaggerated risk of vitamin B12 deficiency after HCV eradication with direct-acting antivirals
    Casas Deza, Diego
    Bernal Monterde, Vanesa
    Fernandez Bonilla, Eva
    Espina, Silvia
    Fernandez Esgueva, Marta
    Martinez-Sapina, Ana
    Fuentes, Javier
    Arbones Mainar, Jose M.
    [J]. JOURNAL OF HEPATOLOGY, 2020, 73 : S605 - S606
  • [6] Comparative effectiveness of direct-acting antivirals for HCV
    Baker, Holly
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (09): : 698 - 698
  • [7] Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals
    Kazuto Tajiri
    Kazuhiko Okada
    Hiroyuki Ito
    Kengo Kawai
    Yoshiro Kashii
    Yoshiharu Tokimitsu
    Nozomu Muraishi
    Aiko Murayama
    Yuka Hayashi
    Masami Minemura
    Terumi Takahara
    Yukihiro Shimizu
    Ichiro Yasuda
    [J]. BMC Gastroenterology, 23
  • [8] A revolution in HCV treatment with direct-acting antivirals: From non-response to eradication
    Asselah, Tarik
    [J]. JOURNAL OF HEPATOLOGY, 2012, 57 (02) : 455 - 457
  • [9] Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals
    Tajiri, Kazuto
    Okada, Kazuhiko
    Ito, Hiroyuki
    Kawai, Kengo
    Kashii, Yoshiro
    Tokimitsu, Yoshiharu
    Muraishi, Nozomu
    Murayama, Aiko
    Hayashi, Yuka
    Minemura, Masami
    Takahara, Terumi
    Shimizu, Yukihiro
    Yasuda, Ichiro
    [J]. BMC GASTROENTEROLOGY, 2023, 23 (01)
  • [10] Stratification of Residual Risk of HCC Following HCV Clearance With Direct-Acting Antivirals in Patients With Advanced Fibrosis and Cirrhosis
    Setiawan, V. Wendy
    Rosen, Hugo R.
    [J]. HEPATOLOGY, 2020, 72 (06) : 1897 - 1899
12345